Clinical Trial: A Study to Evaluate AGN-151586 Intramuscular Injections in Adult Participants for Treatment of Glabellar Lines
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Glabellar Lines
Study Type: INTERVENTIONAL
Official Title: A Phase 3, Multicenter, Randomized, Placebo-Controlled Study of AGN-151586 for the Treatment of Moderate to Severe Glabellar Lines
Brief Summary:
Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin.The purpose of this study is to evaluate the safety and efficacy of AGN-151586 compared to placebo in adult participants.AGN-151586 is an investigational product being developed for the treatment of GL.In the first period, participants are randomly assigned to receive AGN-151586 or placebo.Each group receives a different…
Read more